Revelation Biosciences, Inc. (NASDAQ:REVBW) Short Interest Update

Revelation Biosciences, Inc. (NASDAQ:REVBW) was the recipient of a significant decrease in short interest in April. As of April 30th, there was short interest totaling 48,365 shares, a decrease of 35.0% from the April 15th total of 74,414 shares. Based on an average trading volume of 22,278 shares, the short-interest ratio is currently 2.2 days.

Revelation Biosciences Trading Down 9.5%

Shares of NASDAQ:REVBW traded down $0.00 during trading on Tuesday, hitting $0.01. 58,103 shares of the company were exchanged, compared to its average volume of 93,194. The stock has a 50 day moving average of $0.01 and a 200 day moving average of $0.01. Revelation Biosciences has a 52-week low of $0.01 and a 52-week high of $0.04.

About Revelation Biosciences

Revelation Biosciences, Inc (NASDAQ: REVBW) is a clinical-stage molecular diagnostics company focused on the rapid detection of life-threatening bacterial infections. The company leverages next-generation sequencing (NGS) to analyze cell-free microbial DNA in patient blood samples, with an emphasis on early identification of pathogens in bloodstream infections and hospital-acquired pneumonia. By targeting critically ill patients, Revelation Biosciences aims to shorten time to diagnosis and guide more effective antimicrobial therapy.

The company’s technology platform integrates high-throughput DNA sequencing with proprietary bioinformatics algorithms to differentiate pathogenic microbes from background microbial DNA.